6533b821fe1ef96bd127ba87
RESEARCH PRODUCT
LO3 : Safety and efficacy of the combination daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients from the french observational cohort ANRS CO22 hepather
Christophe HézodeHélène FontaineYves BenhamouJean-pierre BronowickiP. MathurinVentzislava Petrov-sanchezJean-pierre ZarskiJ.-j. RaabeJ. GournayVéronique Loustaud-rattiV. De LedinghenOlivier ChazouillèresJean-claude TrinchetDominique GuyaderC. Dorival-moulyP. NahonIsabelle RosaS. LucierM. BourlièreDominique LarreyFrançois RaffiAlbert TranPatrick MarcellinS. MetivierGhassan RiachiAnne MinelloI. Hubert-fouchardAbou DialloStanislas PolFabien ZoulimFabrice CarratLaurent AlricDidier SamuelDidier SamuelXavier Caussesubject
medicine.medical_specialtyDaclatasvirHepatologySofosbuvir[ SDV ] Life Sciences [q-bio]business.industry[SDV]Life Sciences [q-bio]3. Good healthHcv genotype 1Internal medicineCohortMedicineObservational studybusinessComputingMilieux_MISCELLANEOUSmedicine.drugdescription
International audience; no abstract
year | journal | country | edition | language |
---|---|---|---|---|
2015-04-22 |